-
Something wrong with this record ?
Gastric pH in rats: Key determinant for preclinical evaluation of pH-dependent oral drug absorption
M. Šíma, N. Kutinová-Canová, P. Ryšánek, J. Hořínková, D. Moškořová, O. Slanař
Language English Country Czech Republic
Document type Journal Article
Grant support
Progres Q25
Univerzita Karlova v Praze
SVV 260373
Univerzita Karlova v Praze
NLK
Directory of Open Access Journals
from 2012
Medline Complete (EBSCOhost)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- MeSH
- Proton Pump Inhibitors * pharmacokinetics MeSH
- Hydrogen-Ion Concentration MeSH
- Rats MeSH
- Humans MeSH
- Models, Animal MeSH
- Random Allocation MeSH
- Omeprazole * pharmacokinetics MeSH
- Rats, Wistar MeSH
- Gastric Mucosa * MeSH
- Stomach * chemistry MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Data on gastric pH in rats to be used in preclinical models for pH-dependent drug absorption are still limited or contradictory. The aim of this study was to describe gastric pH in rats at fasted state and to evaluate its changes induced by pentagastrin or omeprazole in order to mimic gastric pH at fasted and fed human subjects. Twenty Wistar rats, fasting for 12 h, were randomly assigned into four treatment groups (n=5): control, pre-treated with omeprazole 2 h before pH measurement, pre-treated with omeprazole 12 h before pH measurement, and pre-treated with pentagastrin 20 min before pH measurement. An incision on the stomach wall was made in anesthetized animals, and pH of gastric juice was measured. The observed pH values were significantly different among groups (p=0.0341), with the median (IQR) values of gastric pH of 3.5 (2.7-4.2), 6.7 (4.7-7.0), 5.6 (3.5-6.4) and 2.2 (1.6-3.1) in control, omeprazole 2 h, omeprazole 12 h and pentagastin group, respectively. We recommend using short interval pentagastrin and 2 h omeprazole pre-treatment in fasting animals to model similar gastric pH as is expected in human fasted and fed state pharmacokinetic studies, respectively.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19021890
- 003
- CZ-PrNML
- 005
- 20190805142512.0
- 007
- ta
- 008
- 190607s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2019.5 $2 doi
- 035 __
- $a (PubMed)31103048
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šíma, Martin $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0222901
- 245 10
- $a Gastric pH in rats: Key determinant for preclinical evaluation of pH-dependent oral drug absorption / $c M. Šíma, N. Kutinová-Canová, P. Ryšánek, J. Hořínková, D. Moškořová, O. Slanař
- 520 9_
- $a Data on gastric pH in rats to be used in preclinical models for pH-dependent drug absorption are still limited or contradictory. The aim of this study was to describe gastric pH in rats at fasted state and to evaluate its changes induced by pentagastrin or omeprazole in order to mimic gastric pH at fasted and fed human subjects. Twenty Wistar rats, fasting for 12 h, were randomly assigned into four treatment groups (n=5): control, pre-treated with omeprazole 2 h before pH measurement, pre-treated with omeprazole 12 h before pH measurement, and pre-treated with pentagastrin 20 min before pH measurement. An incision on the stomach wall was made in anesthetized animals, and pH of gastric juice was measured. The observed pH values were significantly different among groups (p=0.0341), with the median (IQR) values of gastric pH of 3.5 (2.7-4.2), 6.7 (4.7-7.0), 5.6 (3.5-6.4) and 2.2 (1.6-3.1) in control, omeprazole 2 h, omeprazole 12 h and pentagastin group, respectively. We recommend using short interval pentagastrin and 2 h omeprazole pre-treatment in fasting animals to model similar gastric pH as is expected in human fasted and fed state pharmacokinetic studies, respectively.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a žaludeční sliznice $7 D005753
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a modely u zvířat $7 D023421
- 650 12
- $a omeprazol $x farmakokinetika $7 D009853
- 650 12
- $a inhibitory protonové pumpy $x farmakokinetika $7 D054328
- 650 _2
- $a náhodné rozdělení $7 D011897
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 12
- $a žaludek $x chemie $7 D013270
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kutinová-Canová, Nikolína $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0103768
- 700 1_
- $a Ryšánek, Pavel $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0239090
- 700 1_
- $a Hořínková, Jana $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0228030
- 700 1_
- $a Moškořová, Denisa $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0239091
- 700 1_
- $a Slanař, Ondřej $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0058262
- 773 0_
- $w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 120, č. 1 (2019), s. 5-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31103048 $y Pubmed
- 856 41
- $u https://pmr.lf1.cuni.cz/media/pdf/pmr_2019120010005.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 7 $c 1071 $y 4 $z 0
- 990 __
- $a 20190607 $b ABA008
- 991 __
- $a 20190805142635 $b ABA008
- 999 __
- $a ok $b bmc $g 1429470 $s 1060245
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 120 $c 1 $d 5-9 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- GRA __
- $a Progres Q25 $p Univerzita Karlova v Praze
- GRA __
- $a SVV 260373 $p Univerzita Karlova v Praze
- LZP __
- $b NLK111 $a Pubmed-20190607